It was announced this week that FCB Health has selected Dr. Sommer Bazuro, PhD to be their Chief Medical Officer across the US and EU offices. Dr. Bazuro steps into this newly-created position with extensive medical communications experience. Having been with the agency for the past 11 years, she most recently worked at ProHealth, an FCB Health Network company which she started and focused on the medical communications side of the industry. A few years ago, she transitioned to promotional advertising as well.
Her current work has her continuing to lead the New York medical team, managing the EU medical strategists, and also “developing solutions to address the disparity in recruitment of people of color into clinical trials.” The medical team supports both DTC and HCP new business opportunities.
“I’m thrilled to take on this new role, as this is an opportunity to elevate our diverse, best-in-class medical talent even further,” Dr. Bazuro said in the news announcement. “I look forward to ensuring best practices are uniformly implemented across all of our offices in support of our amazing clients, as they continue to bring life-changing therapies to patients in desperate need.”
Dr. Bazuro “holds a PhD in Cell and Molecular Biology from the University of Pennsylvania Medical School, a BS-Research Intensive in Cell and Molecular Biology from Yale University, and she conducted her postdoctoral research fellowship at Memorial Sloan Kettering Cancer Center.”